Literature DB >> 7020438

Treatment of sleepwalking: a controlled study.

W H Reid, I Ahmed, C A Levie.   

Abstract

A single-blind, rater-blind, modified crossover design was used to evaluate a simple, practical method of clinical treatment of sleepwalking. Subjects who had severe somnambulism, but were otherwise free of psychiatric illness, responded well to six brief sessions of specialized hypnotherapy. Follow-up at one year has revealed lasting improvement of both subjective and objective symptoms. A brief review of the subject of sleepwalking, as well as detailed information concerning histories of sleep symptoms and emotional problems in these and other sleepwalkers, is presented.

Entities:  

Mesh:

Year:  1981        PMID: 7020438     DOI: 10.1176/appi.psychotherapy.1981.35.1.27

Source DB:  PubMed          Journal:  Am J Psychother        ISSN: 0002-9564


  7 in total

1.  Sleepwalking.

Authors:  Valérie Cochen De Cock
Journal:  Curr Treat Options Neurol       Date:  2016-02       Impact factor: 3.598

2.  Sleep and violence.

Authors:  Maria Livia Fantini; Monica Puligheddu; Alessandro Cicolin
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

Review 3.  Parasomnias: epidemiology and management.

Authors:  Laurel Wills; John Garcia
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Nocturnal Frontal Lobe Epilepsy vs Parasomnias.

Authors:  Christopher Derry
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

5.  Non-Rapid Eye Movement Parasomnias.

Authors:  Mehran Farid; Clete A. Kushida
Journal:  Curr Treat Options Neurol       Date:  2004-07       Impact factor: 3.598

6.  The treatment of parasomnias with hypnosis: a 5-year follow-up study.

Authors:  Peter J Hauri; Michael H Silber; Bradley F Boeve
Journal:  J Clin Sleep Med       Date:  2007-06-15       Impact factor: 4.062

Review 7.  Behavioural and Cognitive-Behavioural Treatments of Parasomnias.

Authors:  Andrea Galbiati; Fabrizio Rinaldi; Enrico Giora; Luigi Ferini-Strambi; Sara Marelli
Journal:  Behav Neurol       Date:  2015-05-25       Impact factor: 3.342

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.